Fleurieux sur l'Abresle, France

Luc Aujame


Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 38(Granted Patents)


Location History:

  • Fleurieux sur l'Arbresle, FR (2001 - 2003)
  • Fleurieux sur l'Abresle, FR (2004 - 2012)

Company Filing History:


Years Active: 2001-2012

Loading Chart...
6 patents (USPTO):

Title: Luc Aujame: Innovator in Nucleic Acid Technologies

Introduction

Luc Aujame is a notable inventor based in Fleurieux sur l'Abresle, France. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acids and their applications in diagnostics and therapeutics. With a total of six patents to his name, Aujame's work has the potential to impact medical science profoundly.

Latest Patents

Among his latest patents, Aujame has focused on nucleic acids coding for polypeptides specific to pathogenic strains. These inventions include the corresponding polypeptides and their diagnostic and therapeutic applications. His innovative approach addresses critical challenges in the medical field, particularly in identifying and treating diseases caused by these strains.

Career Highlights

Throughout his career, Luc Aujame has worked with prominent organizations such as Aventis Pasteur Limited and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Annabelle Bouchardon and Bachra Rokbi. Their collaborative efforts have further advanced the research and development of nucleic acid technologies.

Conclusion

Luc Aujame's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical diagnostics and therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…